Muhammad Absar, Nawaf Alanazi, Abdulaziz Siyal, Masood Shammas, Amer Mahmood, Sulman Basit, Sarah AlMukhaylid, and Zafar Iqbal. 2022. “CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML”. Journal of Population Therapeutics and Clinical Pharmacology 29 (02): 311-20. https://doi.org/10.53555/jptcp.v29i02.4161.